TScan Therapeutics, Inc. (TCRX)

CIK 1783328 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for TScan Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 2, 202640001193125-26-412518
Oct 2, 202640001193125-26-412521
Sep 30, 20268-K0001193125-26-409199
Sep 25, 2026SCHEDULE 13G0002063423-26-000002
Sep 11, 20268-K0001193125-26-388631
Sep 2, 20268-K0001193125-26-379343
Aug 18, 20268-K0001193125-26-355664
Aug 14, 2026SCHEDULE 13G/A0000921895-26-002183
Aug 14, 2026SCHEDULE 13G/A0000902664-26-003526
Aug 12, 202610-Q0001193125-26-345749
Aug 12, 20268-K0001193125-26-345732
Jun 22, 20268-K0001193125-26-276693
May 22, 20268-K0001193125-26-236862
May 22, 202640001193125-26-236855
May 22, 202640001193125-26-236870
May 22, 202640001193125-26-236848
May 22, 202640001193125-26-236854
May 22, 202640001193125-26-236841
May 22, 202640001193125-26-236844
May 15, 2026SCHEDULE 13G/A0000921895-26-001399
May 6, 202610-Q0001193125-26-207572
May 6, 20268-K0001193125-26-207549
Apr 17, 2026ARS0001193125-26-160310
Apr 17, 2026DEF 14A0001193125-26-160304
Apr 7, 2026PRE 14A0001193125-26-145614